The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells
| Autor: | Susan R. McGlashan, Anna E. S. Brooks, Claire N. Barker, Anandita Umapathy, Sonia Srinivasan, Ashika Chhana, Hilary M. Sheppard, Eloise Williams, Joanna L. James, James I. Hearn |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Stromal cell
Microarray Placenta Cartilage Cell Mesenchymal stem cell Biomedical Engineering Bone Marrow Cells Mesenchymal Stem Cells Physical Therapy Sports Therapy and Rehabilitation Chondrocyte hypertrophy Biology Chondrogenesis Cell biology Glycosaminoglycan Pregnancy Trimester First Chondrocytes medicine.anatomical_structure Pregnancy medicine Humans Immunology and Allergy Female Clinical Research papers |
| Zdroj: | Cartilage |
| ISSN: | 1947-6043 1947-6035 |
| DOI: | 10.1177/19476035211044822 |
| Popis: | Objectives Mesenchymal stem/stromal cells (MSCs) are a well-established cell source for cartilage engineering, but challenges remain as differentiation often results in chondrocyte hypertrophy. Chondrogenic potential also varies with MSC source and donor age. We assessed the chondrogenic potential of first-trimester and term placental MSCs and compared their response to commonly used bone marrow MSCs (BM-MSCs). Design MSCs were isolated from first-trimester and term placentae. BM-MSCs were commercially obtained. Chondrogenesis was induced by micromass culture in commercial chondrogenic media for 7, 14, or 21 days. Pellets were assessed for glycosaminoglycan (GAG) content, and types I, II, and X collagen. Gene expression was profiled using Qiagen RT2 human MSC arrays. Results At day 0, first-trimester and term MSCs expression levels of many chondrogenic genes to BM-MSC after 21 days of culture. Only first trimester MSCs showed significant changes in chondrogenic gene expression during induction compared to day 0 undifferentiated MSCs (greater BMP4, KAT2B, and reduced GDF6 expression). Additionally, first-trimester MSCs showed significantly greater expression of ABCB1 (at days 14 and 21) and BMP4 (at days 7, 14, 21) compared with term MSCs. Both first-trimester and term pellets showed increased GAG content over time and term MSCs had significantly GAG greater compared with BM-MSCs at days 7 and 14. Type II collagen was present in all pellets but unlike BM-MSCs, type I collagen was not observed in first-trimester or term MSC pellets. Conclusions These data highlight differences in BM-MSC and placental MSC chondrogenesis and demonstrate that placental MSCs may be an alternative cell source. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|